The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 888.00
Bid: 894.00
Ask: 904.00
Change: 6.00 (0.68%)
Spread: 10.00 (1.119%)
Open: 896.00
High: 900.00
Low: 878.00
Prev. Close: 882.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

24 May 2023 17:16

RNS Number : 5492A
Mortgage Advice Bureau (Hldgs) PLC
24 May 2023
 

24 May 2023

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Company")

Result of AGM

At the Annual General Meeting ("AGM") of MAB, held earlier today at Capital House, Pride Place, DE24 8QR, all the resolutions put to the meeting were passed.

Summary of AGM Proxy Voting:

For information, the summary of the proxy voting is shown in the table below. The full text of the resolutions is shown in the Notice of the Annual General Meeting, which is available on the MAB website at www.mortgageadvicebureau.com/investor-relations and copies of all special resolutions will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Resolutions

For

Against

Votes at Chair's Discretion

Abstain

1. To receive the annual report and accounts for the year ended 31 December 2022.

51,540,858

0

0

86,520

2. To approve the final dividend of 14.7 pence per ordinary share for the year ended 31 December 2022.

51,625,778

0

0

1,600

3. To approve the Directors' remuneration report for the year ended 31 December 2022.

26,258,785

21,108,556

0

4,260,037

4. To re-elect Katherine Innes Ker as a Director of the Company.

49,311,962

2,312,979

0

2,437

5. To re-elect Peter Brodnicki as a Director of the Company.

50,156,252

1,468,689

0

2,437

6. To re-elect Ben Thompson as a Director of the Company.

51,484,205

140,736

0

2,437

7. To re-elect Lucy Tilley as a Director of the Company.

51,427,477

140,464

57,000

2,437

8. To re-elect Nathan Imlach as a Director of the Company.

51,147,277

477,664

0

2,437

9. To re-elect David Preece as a Director of the Company.

50,155,586

1,468,961

0

2,831

10. To re-elect Mike Jones as a Director of the Company.

51,146,464

477,664

0

3,250

11. To re-appoint BDO LLP as Auditors of the Company.

51,559,208

64,232

0

3,938

12. To authorise the Company's Audit Committee to determine the remuneration of the Auditors.

51,622,545

1,289

0

3,544

13. To authorise the Directors to allot shares in the Company.

51,622,703

1,035

0

3,640

14. To disapply statutory pre-emption rights.*

50,806,027

817,327

0

4,024

15. To disapply statutory pre-emption rights for an acquisition or specified capital investment.*

50,806,027

817,327

0

4,024

The total number of ordinary shares eligible to vote as at 24 May 2023 is 57,127,034.

Board response to Resolution 3 - approval of the Directors' Remuneration Report

While the Board notes that all other resolutions were passed with strong majorities, we acknowledge that the advisory vote on the Directors' Remuneration Report was passed with 55.4%. We have consulted with a number of shareholders and understand that the payment of transaction bonuses was the element of the 2022 remuneration to which a significant number of shareholders objected. We have set out in the 2022 Directors' Remuneration Report the revised remuneration structure adopted from 2023 onwards, with a rebalancing of incentives in favour of longer term objectives, and confirm that in future, transaction bonuses will not be paid.

 

* indicates a special resolution

Enquiries:

Mortgage Advice Bureau (Holdings) plc

  +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Numis Securities Limited

Stephen Westgate / Giles Rolls

 

 

 +44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke

 

+44 (0) 20 7418 8900

Media Enquiries: 

investorrelations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSEMFDLEDSEII
Date   Source Headline
25th Apr 20244:40 pmRNSNotice of Results and AGM
23rd Apr 20244:27 pmRNSGrant of Options and Total Voting Rights
23rd Apr 20247:00 amRNSBoard Changes
17th Apr 20244:57 pmRNSPDMR dealing
15th Apr 20246:09 pmRNSDirector/PDMR Shareholding
28th Mar 20244:01 pmRNSDirectors' Shareholdings and PDMR notification
19th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
15th Mar 20247:00 amRNSDirectors' Shareholdings and PDMR notification
8th Mar 202411:41 amRNSNotification of Major Holdings
29th Feb 20243:21 pmRNSDirectors' Shareholdings and PDMR notification
23rd Feb 20243:25 pmRNSNotification of Major Holdings
19th Feb 20246:17 pmRNSNotification of Major Holdings
19th Feb 20246:15 pmRNSNotification of Major Holdings
14th Feb 20244:09 pmRNSDirectors' Shareholdings and PDMR notification
9th Feb 20247:00 amRNSNotification of Major Holdings
6th Feb 20243:15 pmRNSNotification of Major Holdings
31st Jan 20243:38 pmRNSDirectors' Shareholdings and PDMR notification
26th Jan 20247:00 amRNSNotification of Major Holdings
25th Jan 20247:00 amRNSTrading Update
15th Jan 20243:15 pmRNSDirectors' Shareholdings and PDMR notification
15th Jan 20247:00 amRNSBoard Change
12th Jan 20241:43 pmRNSBlock listing Interim Review
29th Dec 202311:03 amRNSDirectors' Shareholdings and PDMR notification
15th Dec 202310:26 amRNSDirectors' Shareholdings and PDMR notification
30th Nov 20235:57 pmRNSDirectors' Shareholdings and PDMR notification
21st Nov 202311:49 amRNSNotification of Major Holdings
14th Nov 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
3rd Nov 20233:43 pmRNSDirector/PDMR Shareholding
31st Oct 20234:00 pmRNSDirectors' Shareholdings and PDMR notification
16th Oct 20235:07 pmRNSDirectors' Shareholdings and PDMR notification
12th Oct 202311:10 amRNSNotification of Major Interest in Shares
10th Oct 20231:32 pmRNSNotification of Major Interests in Shares
9th Oct 20235:55 pmRNSNotification of Major Interests in Shares
28th Sep 202312:11 pmRNSNotification of Major Holdings
26th Sep 20237:00 amRNSInterim Results
18th Sep 20232:40 pmRNSDirectors' Shareholdings and PDMR notification
31st Aug 20234:43 pmRNSDirectors' Shareholdings and PDMR notification
14th Aug 20233:24 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSStandard form for notification of major holdings
1st Aug 202311:23 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
21st Jul 20232:59 pmRNSNotification of major holdings
18th Jul 20235:34 pmRNSDirectors' Shareholdings and PDMR notification
17th Jul 202312:43 pmRNSDirectors' Shareholdings and PDMR notification
13th Jul 20235:03 pmRNSBlock listing Interim Review
11th Jul 20237:00 amRNSDirectors' Shareholdings and PDMR notification
30th Jun 202312:08 pmRNSDirector/PDMR Shareholding
16th Jun 202311:49 amRNSDirector/PDMR Shareholding
13th Jun 20234:39 pmRNSTR-1: Notification of major holdings
1st Jun 202311:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.